Market Cap
Company ProfileCarisma Therapeutics, Inc. Market Cap History
Market Cap: $67.3 Million
USD as of May 5, 2024
Company Profile $CARMCarisma Therapeutics, Inc. Market Capitalization Over Time
Evolution of Carisma Therapeutics, Inc. market cap history
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $209.25 B |
| Vertex Pharmaceuticals | $121.09 B |
| Regeneron Pharmaceuticals | $78.52 B |
| argenx | $52.93 B |
| Beigene Ltd. | $51.33 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Yearly Market Cap Evolution
| Date | Market Cap | YoY Change |
|---|
Market capitalization is calculated from the opening stock price at the beginning of each year.
Stocks & Indexes
Carisma Therapeutics, Inc. main stocks and indexes inclusions.
$CARMNASDAQ Composite
What is Market Capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.